SOURCE: MediJane Holdings Inc.

April 25, 2014 10:30 ET

Lewis "Spike" Humer Steps Up as New Chairman of MediJane Holdings

LONGMONT, CO--(Marketwired - Apr 25, 2014) - MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company") is pleased to announce that Lewis "Spike" Humer has been named as Chairman and Director of Company. Mr. Humer is also currently CEO of Phoenix Bio Pharmaceuticals Corporation ("Phoenix Bio Pharm"), the Colorado-based developer of certain medicinal cannabis products and delivery systems exclusively licensed to MediJane Holdings in North America.

"I'm very excited to be able to provide additional corporate guidance and oversight to MediJane as it continues to grow and expand as a company and as a brand," commented Lewis "Spike" Humer, Chairman of MediJane Holdings Inc. "Phoenix Bio Pharm and MediJane Holdings share many of the same corporate goals and challenges, so our success can be built together with a growing strategic relationship. I look forward to helping expand MediJane to its full potential as a strong, trusted, and profitable leader in the medical cannabis industry."

Lewis "Spike" Humer is a seasoned business executive with more than twenty years of field proven, sales oriented, and results driven experience. After working with the Susquehanna Pfaltzagraff Company, a company engaged in the manufacturing, distribution, retail sales media, real estate, and more, from 1976 to 1996 in a variety of leadership, managerial, and executive positions, Mr. Humer served as a corporate CEO, COO, Chairman and VP of Sales and VP of Marketing in both public and private enterprises. He has extensive experience as a keynote speaker, professional trainer, organizational consultant, seminar leader, and program facilitator.

From 2001 to 2003, Mr. Humer served as President and CEO of ITEX Corporation, a company engaged in franchise management and administration of an international barter exchange. Mr. Humer designed and implemented a corporate turnaround and organizational restructuring. Prior to joining ITEX Corporation, Mr. Humer served as an executive and consultant to various small-to-midsize enterprises throughout the United States. In addition, Mr. Humer has participated in various other business initiatives including corporate re-engineering, company start-ups, mergers and acquisitions, and raising capital for investment in various business enterprises.

Mr. Humer has been quoted or appeared in a wide of publications such as Equities Magazine, BarterNews, as well as several Business Journals and newspapers throughout the world. Mr. Humer has been featured on such programs as The American Scene Business Radio, World Business Review, Stu Taylor Business Radio, and countless other business broadcasts. In addition, Mr. Humer served as board member for several organizations and corporations, including the Global Board of Directors of the International Reciprocal Trade Association.

About MediJane Holdings Inc. (MJMD)

MediJane Holdings Inc. (MJMD) is in the business of marketing and distributing products within the medicinal marijuana industry, including transdermal patches, capsules, sublingual sprays, and other medical delivery systems. With sales offices opening in California and Colorado, and a planned expansion into a national footprint, MediJane products are designed to give doctors the ability to provide patients accurate and effective doses of cannabinoids to manage and treat pain and other specific illnesses. MediJane's lead product is an innovative non-drowsy "Daytime Pain plus CBD" oral capsule for the treatment of inflammation and chronic, neuropathic, arthritic, and back pain. This smokeless and accurate dose alternative is MediJane's initial launch into the chronic pain management market, which is estimated at over $45 billion annually in North America.

For more information, visit www.medijane.co

Disclaimer/Safe Harbor: Some information in this MediJane Holdings Inc. (MJMD) press release constitutes forward-looking statements or statements which may be deemed or construed to be forward-looking statements. The words "plan", "forecast", "anticipates", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to, known and unknown risks, uncertainties and other factors which could cause MJMD's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to MJMD herein are expressly qualified in their entirety by the above-mentioned cautionary statement. MJMD disclaims any obligation to update forward-looking statements contained in this press release, except as may be required by law.

Contact Information